Academic Detailing Pilot for Naloxone Prescribing Among Primary Care Providers in San Francisco

Family Medicine

Volumn 49, Issue 2, 2017, Pages 122-126

  Behar, Emily ^a,b   Rowe, Christopher ^a   Santos, Glenn Milo ^a   Santos, Nina ^b   Coffin, Phillip O ^a,b  

^a Department of Public Health ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; NARCOTIC ANTAGONIST;

CALIFORNIA; CLINICAL PRACTICE; HUMAN; MEDICAL EDUCATION; OUTCOME ASSESSMENT; PILOT STUDY; PRESCRIPTION; PRIMARY HEALTH CARE; PROCEDURES;

DRUG PRESCRIPTIONS; EDUCATION, MEDICAL, CONTINUING; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; SAN FRANCISCO;

EID: 85012173233     PISSN: 07423225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000-2014. MMWR Morb Mortal Wkly Rep 2016;64(50-51):1378-82.
2. Visconti AJ, Santos GM, Lemos NP, Burke C, Coffin PO. Opioid overdose deaths in the city and county of San Francisco: prevalence, distribution, and disparities. J Urban Health 2015 Aug;92(4):758-72.
3. Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013;346:f174.
4. Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland’s national naloxone programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addiction 2015;Dec 7.
5. Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abuse 2015;36(2):240-53.
6. Stack SJ. A call to action: physicians must turn the tide of the opioid epidemic. AMA Wire 2016;February.
7. AB-831 Drug overdoses. In: California So, ed., February 21, 2013.
8. Dowell D, Haegerich T, Chou R. CDC guideline for prescribing opioids for chronic pain— United States, 2016. Morb Mortal Weekly Rep (MMWR) Recomm Rep 2016.
9. Coffin PO, Fuller C, Vadnai L, Blaney S, Galea S, Vlahov D. Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health 2003 Jun;80(2):288-90.
10. Wilson JD, Spicyn N, Matson P, Alvanzo A, Feldman L. Internal medicine resident knowledge, attitudes and barriers to naloxone prescription in hospital and clinic settings. Subst Abuse Jan 28 2016:0.
11. Green TC, Bowman SE, Zaller ND, Ray M, Case P, Heimer R. Barriers to medical provider support for prescription naloxone as overdose antidote for lay responders. Subst Use Misuse 2013 May;48(7):558-67.
12. Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff. J Gen Intern Med 2015 Dec;30(12):1837-44.
13. Coffin PO. Naloxone for opioid safety. Paper presented at College on Problems of Drug Dependence, June 15, 2015, Phoenix, AZ.
14. Van Hoof TJ, Harrison LG, Miller NE, Pappas MS, Fischer MA. Characteristics of academic detailing: results of a literature review. Am Health Drug Benefits 2015 Nov;8(8):414-22.
15. Lubelchek RJ, Beavis KG, Gonzalez M, Kendrick SR, Roberts RR, Barker DE. Can we broaden the applicability of HIV transmission cluster analyses? AIDS 2012 May 15;26(8):1043-4.
16. Jin M, Gagnon A, Levine M, Thabane L, Rodriguez C, Dolovich L. Patient-specific academic detailing for smoking cessation: feasibility study. Can Fam Physician 2014 Jan;60(1):e16-23.
17. Chhina HK, Bhole VM, Goldsmith C, Hall W, Kaczorowski J, Lacaille D. Effectiveness of academic detailing to optimize medication prescribing behaviour of family physicians. J Pharm Pharm Sci 2013;16(4):511-29.
18. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based “detailing.” N Engl J Med 1983 Jun 16;308(24):1457-63.
19. Soumerai SB, Avorn J. Economic and policy analysis of university-based drug “detailing.” Med Care 1986 Apr;24(4):313-31.
20. Ceasar R, Chang J, Zamora K, et al. Primary care providers’ experiences with urine toxicology tests to manage prescription opioid misuse and substance use among chronic non-cancer pain patients in safety net healthcare settings. Subst Abus 2016 Jan-Mar;37(1):154-60.